CEREZYME Rx

Select the drug indication to add to your list

CEREZYME

Inborn errors of metabolism
Only 4 drugs may be compared at once

Generic Name and Formulations:

Imiglucerase 200 Units, 400 Units; per vial; pwd; for IV infusion after reconstitution.

Select therapeutic use:

Indications for CEREZYME:

For long-term enzyme replacement therapy in patients with confirmed Type 1 Gaucher disease that results in one or more of the following conditions: 1) anemia; 2) thrombocytopenia; 3) bone disease; 4) hepatomegaly or splenomegaly.

Adults and Children:

<2yrs: not recommended. ≥2yrs: Give by IV infusion over 1–2 hours. Individualize. Initial dose range: 2.5 Units/kg 3 times a week to 60 Units/kg once every 2 weeks.

Warnings/Precautions:

Monitor periodically for IgG antibody formation during the first year. Patients previously treated with Ceredase (alglucerase inj) who have developed antibody or hypersensitivity to Ceredase. Monitor for pulmonary hypertension, pneumonia. Pregnancy (Cat.C). Nursing mothers.

Pharmacological Class:

Beta-glucocerebrosidase analogue.

Adverse Reactions:

GI upset, abdominal pain, rash, pruritus, fatigue, headache, fever, dizziness, chills, backache, tachycardia, inj site reactions, hypersensitivity. Also children: dyspnea, flushing, coughing,

How Supplied:

Vial—1

CEREZYME 200 units vials (Qty:1)

appx. price $841.00